Recurrent early pregnancy loss: Can cytogenic analysis help?

Article

Evaluation of recurrent early pregnancy loss, based on this expert's algorithms, should include not only an array of tests but cytogenetic analysis of the products of conception.

Recurrent pregnancy loss has always been an emotionally wrenching experience for our patients. But now, due to technologic advances, miscarriage is becoming even more common among patients. Home pregnancy tests have become so sensitive that women are acutely aware of miscarriages that occur before they even miss a period. Also, with the expanding use of ultrasound monitoring for ovulation induction and in vitro fertilization, women are increasingly aware of pregnancy losses not long after embryo transfer. It's not surprising then that they are seeking evaluation and management of repeated preclinical miscarriages-and we must be ready to offer them appropriate guidance. With that in mind, my goal here is to help clinicians understand the impact of such early pregnancy testing, so we can offer patients that guidance.

Recurrent pregnancy loss is usually defined as two or more pregnancy losses at any gestational age. Recurrent miscarriage is more strictly defined as three or more consecutive miscarriages. The term early refers to pregnancies that end in demise before 10 weeks of gestation, while preclinical refers to those ending before 6 weeks of gestation. Incorporating such descriptive terminology permits us to easily summarize a patient's pattern of presentation.

Recent Videos
Supreme Court upholds mifepristone access: Implications for women's health | Image Credit: linkedin.com
The significance of the Supreme Court upholding mifepristone access | Image Credit: unchealth.org
One year out: Fezolinetant displays patient satisfaction for managing hot flashes | Image Credit: sutterhealth.org
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit: cdc.gov
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit: shrinerschildrens.org
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:  uofmhealth.org.
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit: uclahealth.org.
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit: mayo.edu.
© 2024 MJH Life Sciences

All rights reserved.